Tyra Biosciences, Inc. · NASDAQ:TYRA
Commodore Capital LP's stake in Tyra Biosciences, Inc. fell to 4.20% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Commodore Capital LP's stake in Tyra Biosciences, Inc. fell to 4.20%, 2,475,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 4.20%
- Shares
- 2,475,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 4.20% | 2,475,000 |
| Commodore Capital Master LP | 4.20% | 2,475,000 |
| Robert Egen Atkinson | 4.20% | 2,475,000 |
| Michael Kramarz | 4.20% | 2,475,000 |
Source
Related
- Tyra Biosciences, Inc.
- Commodore Capital LP
- Tyra Biosciences, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · Nov 14, 2025
- Schedule 13G · Commodore Capital LP · May 14, 2025
- Schedule 13G · Biotechnology Value Fund L P · Sep 21, 2026
- Form 4 · Harris Todd · Sep 17, 2026
- Form 4 · Rueb Yuliya · Sep 17, 2026
- Form 4 · Fuhrman Alan · Sep 17, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 17, 2026